PMID: 9169297May 1, 1997Paper

Differential effects of three 5-HT receptor antagonists on the performance of rats in attentional and working memory tasks

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
S RuotsalainenP Riekkinen

Abstract

The effects of three different serotonin (5-HT) receptor antagonists (ketanserin, methysegide, methiothepin) in the modulation of attention, working memory and behavioural activity were investigated in this study by assessing the performance of rats in two separate cognitive models; the 5-choice serial reaction time (5-CSRT) task, which measures attention, and the delayed non-matching to position (DNMTP) task, which measures working memory. Methysergide and methiothepin bind at the 5-HT1 and 5-HT2 as well as the 5-HT5-7 receptors, with varying degrees of selectivity, and ketanserin binds at the 5-HT2A receptors rather selectively. None of these agents bind to any significant extent to 5-HT3 or 5-HT4 receptors. In the 5-CSRT task, neither methiothepin (0.15 mg/kg) nor ketanserin (1.0 and 3.0 mg/kg) impaired the choice accuracy of rats, although they induced sedation. The low doses of methysergide (1.5 and 3.0 mg/kg) slightly increased the behavioural activity of rats, whereas the high dose of methysergide (15.0 mg/kg) reduced behavioural activity and slightly reduced choice accuracy of the rats in the attentional task (monitoring of visual stimuli) under the baseline conditions or curtailed stimulus duration. This effect was not...Continue Reading

References

Apr 1, 1992·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·D A McCormick
Jan 11, 1992·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·P JäkäläP Riekkinen
Jan 1, 1992·Neuroscience and Biobehavioral Reviews·D N Middlemiss, M D Tricklebank
Apr 1, 1991·Pharmacology, Biochemistry, and Behavior·A L Markowska, G L Wenk
Jan 1, 1988·Psychopharmacology·S B DunnettS D Iversen
Dec 1, 1984·Neuropharmacology·J E Blundell
Jan 1, 1983·Pharmacology, Biochemistry, and Behavior·W W Beatty, J R Rush
Jul 1, 1994·Progress in Neurobiology·J SirviöP J Riekkinen
Jan 1, 1993·Psychopharmacology·S L Handley, J W McBlane
Oct 29, 1993·Science·M SteriadeT J Sejnowski
Aug 1, 1993·Pharmacology, Biochemistry, and Behavior·A Sahgal, A B Keith
Feb 1, 1993·Pharmacology, Biochemistry, and Behavior·P JäkäläP J Riekkinen

❮ Previous
Next ❯

Citations

Feb 1, 2005·Psychopharmacology·Amir H RezvaniEdward D Levin
Jan 23, 1999·Biological Psychiatry·J I FriedmanK L Davis
Jul 19, 2000·Pharmacology, Biochemistry, and Behavior·C Wilson, M Pulido
Jan 22, 2000·Neuroscience and Biobehavioral Reviews·A Meneses
Sep 17, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stan B Floresco, James D Jentsch
Nov 30, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Emma S J RobinsonTrevor W Robbins
Nov 29, 2014·Current Addiction Reports·Marci R Mitchell, Marc N Potenza
Feb 5, 2016·Pharmacological Reviews·David E Nichols
Sep 19, 2012·European Psychiatry : the Journal of the Association of European Psychiatrists·E Kiive, J Harro
Oct 27, 2015·Frontiers in Pharmacology·Gongliang Zhang, Robert W Stackman
Mar 18, 2011·British Journal of Pharmacology·Catharine A Winstanley
Sep 28, 2005·Pharmacology, Biochemistry, and Behavior·Edward LevinAshkan Farzad
Nov 19, 2011·The International Journal of Neuropsychopharmacology·Neil E PatersonTaleen Hanania
Sep 8, 2006·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Ana Paula M GuimarãesMara H Hutz
Jan 16, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Alp UçokGüher Saruhan-Direskeneli
May 6, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Carli MirjanaClaudia Balducci

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.